Atlas Trials

FLT3-mutated Acute Myeloid Leukemia

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch FLT3-mutated Acute Myeloid Leukemia

RecordFirmDate
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML (NCT03591510)Novartis Pharmaceuticals2019-03-13
Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) (NCT02829840)M.D. Anderson Cancer Center2016-09-01
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia. (NCT02310321)Astellas Pharma Inc2015-02-26
An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) (NCT03114228)Novartis Pharmaceuticals

Track FLT3-mutated Acute Myeloid Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.